Understanding the Cause of a Rare & Aggressive Childhood Leukemia
With support from both the St. Baldrick’s Foundation and the American Cancer Society, analysis of data from over 5,000 kids with cancer may provide new opportunities for diagnosis, prognosis, and treatment of pediatric acute myeloid leukemia (AML).
Research Outcomes: Unveiling Hope
Our St. Baldrick’s Foundation Research Outcomes blogs highlight examples of the progress your donations are supporting. This quarterly edition focuses on understanding how rhabdomyosarcoma grows, using immunotherapy to treat pediatric brain tumors and relapsed neuroblastoma, as well as research to understand the experiences of adolescents and young adults being treated for advanced pediatric cancer.
Thank you for making research – and hope — possible.
Combined Efforts: First Partnership Grants of the St. Baldrick’s Foundation and the American Cancer Society
When a patient is fighting cancer, a combination of two cancer treatments often works better than just one. Since August of 2019, another kind of combination has been at work to fight childhood cancers: A partnership between the St. Baldrick’s Foundation and the American Cancer Society.
Today we are excited to announce the first set of research projects to be supported by this partnership, totaling more than $2.8 million.
SBF
Tweets »
